Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

People from minoritised groups in the UK experience a complex and interconnected set of factors that increase their risk of harm when using NHS services, according to a new qualitative study by researchers at the Nuffield Department of Population Health and the London School of Hygiene & Tropical Medicine. The study is published in BMJ Open Quality.

Medical staff working in a hospital

The study draws on in-depth interviews with 48 people from minoritised groups from across the UK who reported harm from NHS treatment, delays in care, or lack of access to services. Participants were selected on the basis of ethnicity, faith, disability, sexual orientation or gender identity, with many reporting more than one of these characteristics.

The researchers used a socio-ecological framework to explore how contributory factors to harm operate across five levels: individual, interpersonal, community, organisational and societal.

Key findings:

  • Most participants described experiencing moderate or severe physical and/or psychological harm, often with long-lasting impacts on their health and wellbeing;
  • Participants described a wide range of experiences that contributed to health-related harm, including delayed diagnoses, inadequate pain management, poor coordination of care, and dismissive or discriminatory interactions with healthcare professionals. Many said they felt ignored, stereotyped or treated as a burden, which left them feeling unsafe, losing trust and reluctant to seek further NHS care;

 

 

Read the full story on the Nuffield Department of Population Health website.

Similar stories

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.

Robotic hip and knee surgery fails to cut overall risk of repeat surgery

Two major studies from the University of Oxford, Queen Mary University of London and the University of Bristol, have found that robotic-assisted hip and knee replacement does not reduce the overall early risk of repeat surgery compared with conventional surgery.

Oxford medical student takes AI safety message to the Palace of Versailles

Oxford medical student Julian Shellard has presented at an international workshop on the future of Artificial Intelligence (AI) at the Palace of Versailles in Paris, highlighting the important role medical students can play in global conversations on shaping the future of science and medicine.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group at the MRC Weatherall Institute of Molecular Medicine, have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Dunn School publishes new children’s book to mark centenary

The collaboration with Oxford University Press brings the story of the development of Penicillin to a new audience